View printer-friendly version << Back
MEDNAX to Present at J.P. Morgan Healthcare Conference

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jan. 7, 2009--MEDNAX, Inc., (NYSE:MD) today announced that it is scheduled to make a presentation on Wednesday, January 14, at 8:30 a.m. Pacific Time, to investors attending the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

The presentation by MEDNAX's Chief Executive Officer, Roger J. Medel, M.D., will be broadcast through a live audio Webcast and will be available for replay at


MEDNAX, Inc., through its subsidiaries, is a national medical group that encompasses the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Founded in 1979 as a neonatal physician group, MEDNAX's Pediatrix subsidiary includes neonatal physicians who provide services at more than 250 neonatal intensive care units, and in many markets they collaborate with affiliated maternal-fetal medicine, pediatric cardiology physician subspecialists and pediatric intensivists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,200 physicians in 32 states and Puerto Rico. Additional information is available at

    CONTACT: MEDNAX, Inc., Fort Lauderdale
             Bob Kneeley, Director, Investor Relations
             954-384-0175, Ext. 5300

    Source: MEDNAX, Inc.